Navigation Links
Halozyme Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/5/2010

These two studies, one in type 1 diabetes patients and the other in type 2 patients, will each enroll approximately 110 patients. The primary endpoint will be a comparison of glycemic control, as assessed by the change in A1C from baseline.
  • An equity financing raised net proceeds of $60 million through a public offering of 8.3 million newly issued shares of common stock. The offering closed on September 14, 2010.
  • Halozyme completed its root cause investigation regarding HYLENEX manufacturing and has identified a corrective action plan and regulatory strategy to reintroduce HYLENEX to the market. We have been in communication with the U.S. Food and Drug Administration (FDA), and have provided them materials relating to the root cause and remediation plans.
  • Recently, Halozyme redirected its resources to concentrate on advancing its core proprietary programs through key clinical inflection points in 2011 and 2012, and to support its strategic alliances with Roche and Baxter. Halozyme will continue full development of its Phase 2 Ultrafast Insulin, Phase 1 PEGPH20, and preclinical HTI-501 programs, and has decreased research relating to the discovery and preclinical assessment of new compounds. This strategy resulted in reduction in the workforce of approximately 25 percent.
  • Baxter presented two posters with interim data from its Phase 3 clinical trial of HyQ at the European Society for Immunodeficiencies meeting in Istanbul, Turkey on October 6-9, 2010. HyQ is an immunoglobulin therapy facilitated subcutaneously by Halozyme's recombinant human hyaluronidase. Interim analyses showed that 28 out of 29 HyQ-treated study participants with primary immune deficiency were able to infuse immunoglobulin under the skin, using a single injection site, at infusion volumes, intervals and rates equivalent to their previous intravenous (IV) administration of immunoglobulin. 
  • Roche presented a poster of its Phase 1 clinical trial for Her
    '/>"/>

  • SOURCE Halozyme Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    2. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
    3. Halozyme Therapeutics to Present at Upcoming Investor Conferences
    4. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
    5. Halozyme Therapeutics to Host Research Day for Investors and Analysts
    6. Halozyme Therapeutics to Present at Upcoming Investor Conferences
    7. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
    8. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
    9. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
    10. Halozyme Receives $5.5 Million Payment From Baxter
    11. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... -- Research and Markets has announced the ... report to their offering. ... the genetic material or genomes of an organism. It ... discovery and development of diagnostic and therapeutic solutions for ... is supported by three major product segments: Instruments, Consumables, ...
    (Date:7/31/2014)... and SHENZHEN, China , ... announced today the purchase of an Irys™System ... BGI selected BioNano,s platform to enable comprehensive exploration of ... assemblies for various organisms of interest, including those where ... partner together to develop new methods for multiplexing on ...
    (Date:7/31/2014)... (PRWEB) July 31, 2014 Although ... of the first transcriptome-wide analyses appearing around 2008, ... assay for RNA measurement. In the last several ... more specific, work with smaller input amounts, process ... (eg, blood samples). On the bioinformatics side, there ...
    (Date:7/31/2014)... The Kidney Cancer Association (KCA) has established a ... Kidney Cancer News. , Bill Bro, KCA CEO, says, ... by an international news organization. When we began using iReport ... This month’s program highlights news of an enzyme that is ... recent study. Kidney Cancer News also presents a report on ...
    Breaking Biology Technology:Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2
    ... 2012   Spherix Incorporated (NASDAQ: SPEX) – ... metabolic syndrome and atherosclerosis, and provider of technical ... and pharmaceutical companies, today reported the successful completion ... drug candidate, SPX-106.  Results demonstrated an ample margin ...
    ... IndustryWeek magazine today named the Life ... Austin, Texas, one of its Top Ten Plants in North ... win the prestigious award.  IndustryWeek noted the plant,s ... since 2007; 94% error reduction in production documentation process; $4.2 ...
    ... , Troy, N.Y. Engineering researchers at Rensselaer Polytechnic ... nanomaterials that could lead to highly efficient refrigerators and ... The key ingredients for this innovation are a dash ... At the heart of these solid-state cooling systems ...
    Cached Biology Technology:Spherix Announces Successful Completion of Important Toxicology Study of SPX-106 2Spherix Announces Successful Completion of Important Toxicology Study of SPX-106 3Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 2Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 3Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 4Nature Materials: Quick-cooking nanomaterials in microwave to make tomorrow's air conditioners 2Nature Materials: Quick-cooking nanomaterials in microwave to make tomorrow's air conditioners 3Nature Materials: Quick-cooking nanomaterials in microwave to make tomorrow's air conditioners 4
    (Date:7/31/2014)... CORAL SPRINGS, Florida , July 31, 2014 /PRNewswire/ ... compete to develop unique and innovative smart technologies; companies ... Inc. (NASDAQ: EBAY ), Amazon.com Inc. (NASDAQ: ... FB ), Google Inc. (NASDAQ: GOOG ) ... OTCQB) a biometric authentication company focused on the growing m-commerce ...
    (Date:7/30/2014)... The black truffle uses reversible epigenetic processes to regulate ... The ,methylome, - a picture of the genome regulation ... open access journal Genome Biology and illustrates ... elements and ,jumping genes,. The authors say this may ... are controlled. , Black truffles (Tuber melanosporum), also known ...
    (Date:7/30/2014)... shortest distance between two points is a straight line, ... been taking the familiar axiom to heart. , ... be intense, with each racing for the chance to ... sperm form cooperative groups that allow them to take ... new study, conducted by Heidi Fisher, a post-doctoral student ...
    Breaking Biology News(10 mins):Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6How black truffles deal with the jumpers in their genome 2When cooperation counts 2When cooperation counts 3
    ... preference for speech through in-utero eavesdropping, or is their ... test, but one that's central to understanding the origins ... a McGill University psychologist believes she's separated out the ... results, says Dr. Athena Vouloumanos, point to a genetic ...
    ... University of Pennsylvania School of Medicine discovered that a ... internal molecular clock in mammals. What's more, this molecule ... light on circadian rhythm disorders, including bipolar disorder. The ... metabolism, are reported in this week's issue of Science. ...
    ... Scientists supported by the National Institute of Allergy and ... Health (NIH), have identified a defect in the immune ... that puts them at risk of developing serious complications ... Ph.D., of the National Jewish Medical and Research Center ...
    Cached Biology News:Born with a love of speech 2Born with a love of speech 3Clock molecule's sensitivity to lithium sheds light on bipolar disorder 2Defective immune system response to smallpox vaccine detailed in new study 2Defective immune system response to smallpox vaccine detailed in new study 3
    Buffer used for mitocapture assays....
    ... Kit, 25 purifications. Allows rapid ... efficient removal of unincorporated CyDye label ... superior yields of labeled cDNA probe. ... cDNA labeled by either direct incorporation ...
    Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
    Detects activated caspases in living cells. Simple/sensitive/straight-forward procedure takes only 30 minutes. Results can be analyzed by flow cytometry/fluorescence microscopy/fluorescence plate rea...
    Biology Products: